Summarized by Plex Health
Last Updated: 03 May 2022

Throughout the first trimester of pregnancy, women are consistently offered a selection of testing tests to assess the risk for congenital diseases in the unborn child. The researchers found that women in the intervention group racked up considerably higher in their understanding of genetic testing compared to the control group. Women in the intervention group were more likely to properly identify the chance that an amniocentesis will cause a miscarriage and the possibility that their unborn child had Down syndrome. The variety of women that picked prenatal testing alone was comparable, 68. 5% in the intervention group vs. 67. 3% in the control group. "This does not indicate that women in general don't want testing, Kuppermann states. Decisions about prenatal testing are personal and ought to be reflective of the patient's own values and choices, not those of her health-care providers," Kuppermann says. , by Vicki Contie. At your first prenatal see, your healthcare provider will test for a number of points, including troubles with your blood, signs of infections, and whether you are unsusceptible to rubella and chickenpox. Throughout your pregnancy, your health and wellness care provider might suggest a number of other tests, too. There are 2 types of tests: Screening tests are tests that are done to see if you or your baby could have specific troubles. It does not suggest that there is an issue if your screening test result is abnormal. Your healthcare provider can clarify what the test results mean and possible following actions. Analysis tests show whether or not you or your infant have a particular problem. You and your health and wellness care provider can go over the threats and benefits of the tests, and what type of details the tests can give you. The most common type of EB, epidermolysis bullosa simplex, is the least severe, yet can still cause skin blistering beginning at birth when the infant's fragile skin is subjected to the trauma of delivery. The researchers' next goal is to develop a test whereby the disease can be identified noninvasively with a blood test that discovers fetal DNA in the mommy's bloodstream, perhaps as early as the 5th week of gestation. The mission of the National Institute of Arthritis and Musculoskeletal and Skin Diseases, a part of the Department of Health and Human Services' National Institutes of Health, is to support research into the causes, treatment, and avoidance of arthritis and bone and joint and skin diseases; the training of fundamental and scientific scientists to accomplish this research; and the circulation of information on research progress in these diseases.

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions

** If you believe that content on the Plex is summarised improperly, please, contact us, and we will get rid of it quickly; please, send an email with a brief explanation.

*** If you want us to remove all links leading to your domain from and never use your website as a source of the "Online Knowledge", please contact us using a corporate email and we will remove everything in 10 business days.


Plex Page is a Biology & Health Sciences "Online Knowledge Base," where a machine summarizes all the summaries.